Latest News
Biofortuna appointed as CMO for QuantuMDx CE–marked assay
In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure business continuity at Biofortuna.
Coronavirus Update from Biofortuna
In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure business continuity at Biofortuna.
Biofortuna unveils ampDRY™ air-dried master mix
Biofortuna (Liverpool, UK) – the international IVD contract research and contract manufacturing company – will be launching ampDRY™, its patent pending stabilised master mix for PCR applications, at the AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago, July 29 to August 2. ampDRY hotstart master mix has been developed to enable complete end-stage or real-time PCR assays to
Latest News
Biofortuna is an expert provider of contract IVD development & manufacturing services for molecular and immunoassays. Being ISO13485 certified and FDA registered, we are your partner of choice for taking your assay from initial concept through manufacture and to market.
Biofortuna now offers a comprehensive range of genomic services.
Biofortuna Limited © 2020 |